Lataa...
1α,25-Dihydroxyvitamin D(3)-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action
Synthesis of 1α,25-dihydroxyvitamin D(3)-3β-bromoacetate (1,25(OH)(2)D(3)-3-BE), a potential anti-cancer agent is presented. We also report that mechanism of action of 1,25(OH)(2)D(3)-3-BE may involve reduction of its catabolism, as evidenced by the reduced and delayed expression of 1α,25-dihydroxyv...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3073821/ https://ncbi.nlm.nih.gov/pubmed/21392983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2011.02.025 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|